Quick Links
Meet
the Commercial Team
Super User
Bimeda Welcomes Ben Siegfried
Bimeda® is pleased to announce the appointment of Ben Siegfried as a Regional Strategic Sales Manager for the states of Nebraska and Iowa. Ben will be an integral part of the livestock sales team and assist in the development and management of both core Bimeda products and the bovine vaccine lines. He will assist the livestock sales team by facilitating the growth and expansion of the territory and development of key account business.
Ben is a Western Nebraska native with nearly 20 years of experience in multiple segments of animal health working for distribution and manufacturing.
Bimeda is very proud to add Tim to our growing food animal business unit.
Bimeda Welcomes Tim Blackstone
Bimeda® is pleased to announce Tim Blackstone in the new role of Territory Sales Manager for the Upper Midwest/Plains including the states of North Dakota, South Dakota, Minnesota, and Wisconsin. Tim will be an integral colleague as part of the food animal sales team and be responsible for both core Bimeda products and the recently acquired bovine biologicals commercial and custom vaccine lines. He will also assist with the business development of Bimeda with key Veterinary clinics, dairies, and producers within his territory.
Tim has 26 years of experience within the animal health industry as a distribution representative and, most recently, 20 years for Merck Animal Health..
Bimeda is very proud to add Tim to our growing food animal business unit.
Resources
Detailers
- Stimulator Detailer
- Stimulator 5 + PMH Detailer
- Pro-Bac - Features Benefits & Comparisons to Other Products
- Pro-Bac - Overview & Importance of Prevention
- Pro-Bac + Myco-Bac Comparison Chart
Technical Bulletins
- U.S. M. haemolytica Serotype A Prevalance
- M. haemolytica in Bovine Respiratory Disease (BRD)
- MLV Comparison in Commercial Feedlot
- Pro-Bac Administration Guide
Product Labels
Detailer
Technical Bulletin
- A Comparison of Different Adjuvants in Streptococcus suis Autogenous Vaccines
- Comparison of the Efficacy of Various Autogenous Streptococcus suis Vaccine Formulations containing StabligenTM Adjuvants in Reducing Piglet Mortality
- Suilysin (SLY) is an indicator of Streptococcus suis derived capsule 1 pathogenesis only
Dr. Dave Ellefson
Director of Technical Services
North America
Contact Us
Bimeda Biologicals Inc.
1702 North Bell Street, San Angelo, Texas, 76903
1 800 284 8403 (toll free)
325 653 4505
Bimeda Biologicals Introduces Dr Paul Lawrence, Research and Development Director
We welcome Dr. Paul Lawrence as the Research and Development Director for Bimeda Biologicals. Dr. Lawrence will manage and provide strategic direction in the development of USDA approved products and the development of autogenous vaccines. His primary focus will be on establishing support for the swine autogenous business and the diagnostic lab and research facilities.
We look forward to Dr. Lawrence's contributions to our growth and success.
Bimeda Welcomes David Christian
Bimeda® is pleased to announce the appointment of David Christian as a Strategic Sales Account Manager for the Livestock Southern Region (Texas, Oklahoma and Eastern New Mexico). David will work as part of the livestock sales team helping in the management and sales of both traditional Bimeda products and the development of the newly acquired Bimeda Biologicals brand of cattle vaccines.
David has 23 years of experience in the animal health industry, focusing in the confined feeding area.
Bimeda is very proud to add David to our growing Livestock Sales group.
DIAGNOSTICS
When fighting diseases that threaten your herd—and your profitability—it is important to know what you are up against
As disease challenges affecting livestock continue to evolve, and new or uncommon pathogen strains emerge, knowing what it is you are up against can save you a lot of time and money. Bimeda Biologicals’ diagnostic and testing labs use the latest technology to assist you in providing the highest level of care for your animals. Our experienced staff is dedicated to getting you accurate information, as quickly as possible, so that you can make better, science-based management decisions.
Available Services + Testing Capabilities:
- Virus Detection, Isolation + Identification
- Bacteria Detection, Isolation + Identification
- Antibiotic Sensitivity Testing
- Isolate Selection for Vaccine Formulation + Combination
- Autogenous Vaccine Candidate Isolate Management
- Bovine Pregnancy Testing
- BVD-PI ELISA Testing
- Sample Types: ear notch or blood sample
- Kit Types: IDEXX® and Central States Testing
If you have any questions or would like more information on our diagnostic services, contact us.
Bimeda USA
Bimeda® Biologicals
1702 North Bell Street,
San Angelo, Texas
76903
Phone: 1 800 284 8403
NO SMOKE & MIRRORS.
JUST SOLID SCIENCE.
Stimulator® vaccines were designed to stimulate a strong, protective immune response in stocker and feeder cattle against the five most common viral pathogens associated with Bovine Respiratory Disease (BRD):
- Infectious Bovine Rhinotracheitis (IBR)
- Bovine Viral Diarrhea Type 1 (BVD I)
- Bovine Viral Diarrhea Type 2 (BVD I)
- Bovine Respiratory Syncytial Virus (BRSV)
- Parainfluenza3 (PI3)
DOWNLOAD | STIMULATOR DETAILER
Why Choose Stimulator Vaccines?
RELEVANT
Stimulator vaccines were developed 10-20 years after most other commonly used straight MLV vaccines. As a result, an additional decade’s worth (or more) of insights and understanding were used to build Stimulator vaccines. We selected strains to maximize cross-protection against the most prevalent subtypes affecting your cattle.
QUALITY
All viral antigens contained in Stimulator vaccines have been genetically tested to confirm stability and purity to ensure they have not mutated during the production process.
SAFE
Unlike most MLV’s for cattle, no fetal bovine serum is used at any stage of production of the viruses or the cells contained in Stimulator vaccines. This guarantees that no extraneous, unwanted bovine viruses are introduced from fetal bovine serum.
EFFICACY
Stimulates protective immunity so your cattle are better equipped to remain healthy and productive when faced with common viral challenges.
PROTECT YOUR CATTLE AND YOUR
BOTTOM LINE.
Our PRO-BAC™ vaccine line was developed specifically for stocker and feeder cattle and offers the most complete protection against five of the most common BRD-causing bacteria:
- Mannheimia haemolytica Type A1 (MhA1)
- Mannheimia haemolytica Type A6 (MhA6)
- Pasteurella multocida (Pm)
- Histophilus somni / Haemophilus somnus (Hs)
- Salmonella typhimurium (St)
No other vaccines available on the market can say the same.
All of the PRO-BAC vaccines are powered by our proprietary adjuvant Reveal ATS™. Learn more about the Reveal ATS Advantage
DOWNLOAD PRO-BAC - FEATURES, BENEFITS & COMPARISONS TO OTHER PRODUCTS PRO-BAC - OVERVIEW & IMPORTANCE OF PREVENTION PRO-BAC ADMINISTRATION GUIDE
Why Choose PRO‑BAC VACCINES?
QUALITY BACTERIAL ANTIGENS
Our antigens are grown in specific conditions to maximize expression of all virulence factors, which optimizes post-injection antigen presentation in order to elicit a stronger immune response to better protect your cattle against the bacterial challenges they may face later on—whether that is on the ranch or in the feedlot.
CONVENIENCE
Available in both 50-dose and 100-dose bottles, PRO-BAC vaccines come ready-to-use requiring no chute-side mixing and are administered in a BQA-friendly 2.0 mL subcutaneous (SQ) dose in the side of the neck.
VERSATILITY
Choose the right antigen combination to plug into your current vaccination protocol to fill the gaps other vaccines aren’t covering to set your calves up to perform on the ranch and in the feedlot.
EFFICACY
Our unique manufacturing process and proprietary adjuvant system (Reveal ATS™) results in vaccines that provide a high level of protection against the costliest BRD-causing bacteria without the harsh side effects often associated with the vaccination of mid- to high-risk cattle.
Learn more about the Reveal ATS Advantage
DEALING WITH HIGH PULL RATES, POOR TREATMENT RESPONSE AND SWOLLEN JOINTS IN RECENTLEY WEANED CALVES?
YOUR VACCINE PROTOCOL MAY BE MISSING A KEY PIECE.
Mycoplasma bovis is one of the most prevalent of all the bacterial pathogens affecting young cattle during periods of elevated stress such as weaning and transportation. In general, the higher the “risk classification” of a particular group of cattle the greater the possibility of a Mycoplasma problem. Read
The typical “myco” infections begin to show up about 3 weeks after exposure and can cause respiratory disease as well as crippling arthritis. Due to it’s extremely small cell size and lack of a ridged cell wall, many antibiotics are rendered ineffective against M. bovis resulting in increased pull rates, poor treatment response and unusually high death rates.
MYCO-BAC® was the first fully licensed Mycoplasma bovis (also referred to as ‘Mycoplasma’ or ‘Myco’) vaccine approved by the USDA in 2002. It was originally developed by the team at Texas Vet Lab, Inc. following years of clinical observation and diagnostic/laboratory research as well as significant experience producing effective autogenous vaccines for feedlot and stocker veterinarians and consultants from across the country.
MYCO-BAC is powered by our proprietary adjuvant Reveal ATS™. Learn more about the Reveal ATS Advantage
DOWNLOAD | MYCO-BAC LABEL
The Benefits of Vaccinating with MYCO‑BAC
COST SAVINGS
When it comes to Mycoplasma bovis, prevention is almost always cheaper than treatment. Not only will a myco infection negatively impact cattle’s’ performance by keeping them off feed and water, effective treatment options are limited which often leads to high labor and drug expenses.
REDUCED MORBIDITY & MORTALITY
Field trials coupled with expansive experience and understanding of the disease support that giving MYCO-BAC, according to the labeled 3-dose regiment administered on days 0, 7 and 14, will reduce morbidity and mortality as well as increase treatment response success in vaccinated cattle.
EFFECTIVE
Our unique manufacturing process combines quality bacterial antigen with our proprietary adjuvant system (Reveal ATS™) to create a strong, specific immune response to prevent and control respiratory disease due to M. bovis.
Learn more about the Reveal ATS™ Advantage
PREVENTING THE PREVENTABLE
WITH AN EFFECTIVE COMBINATION.
An effective combination vaccine that helps protect cattle against some of the most common—and costly—viral and bacterial pathogens associated with Bovine Respiratory Disease (BRD).
Available Sizes
10 dose, 50 dose
DOWNLOAD | STIMULATOR 5 + PMH DETAILER